Acetyl tetrapeptide-5
is used in cosmetic eye formulations to decrease puffiness, eye bags, and dark circles by reducing edema and protecting proteins such as SOD from glycation
Alanine
Ala / A · hydrophobic residue · neutral charge
AOD-9604
is studied as an anti-obesity peptide that can reduce weight gain and increase fat oxidation in obese animal models with generally neutral effects on IGF-1 and glucose metabolism in early human trials
Arginine
Arg / R · basic residue · positive charge
Argireline
is a topical cosmetic peptide reported to decrease dynamic wrinkles by partially mimicking the mechanism of botulinum toxin in a non-invasive manner
Asparagine
Asn / N · polar residue · neutral charge
Aspartic acid
Asp / D · acidic residue · negative charge
BPC-157
is investigated for accelerating healing of gastrointestinal mucosa, tendons, ligaments, bone, and nervous tissue in preclinical models, with anti-inflammatory and pro-angiogenic effects
Comparison
While MOTS-c improves insulin sensitivity, enhances glycolysis, reduces oxidative stress, and shows protective effects in models of metabolic syndrome, aging, and ischemia-reperfusion injury8135146, Thymosin Beta-4 promotes wound healing, angiogenesis, and tissue regeneration in preclinical models via effects on cytoskeleton dynamics, cell migration, and anti-apoptotic pathways25579.
While MOTS-c works as a 16-amino-acid mitochondrial-derived peptide that translocates to the nucleus under metabolic stress and regulates glucose and lipid metabolism largely via activation of AMPK and modulation of mTOR and folate-cycle–linked pathways854140146, Thymosin Beta-4 is an endogenous 43-amino-acid actin-sequestering peptide that maintains a pool of G-actin monomers and regulates actin polymerization, thereby influencing cell migration, proliferation, and differentiation25579.
MOTS-c
MT-RNR1
Thymosin Beta-4
TMSB4X
MOTS-c and Thymosin Beta-4 are noticeably different, with limited direct overlap in their usual biological context. Their typical research and application settings separate fairly clearly: MOTS-c is more often discussed in the realm of Metabolic and endocrine and Aging and longevity, whereas Thymosin Beta-4 is more often associated with the realm of Musculoskeletal health, Cardiovascular health, and Dermatology and aesthetics. Their biological logic is quite different: MOTS-c is a gene expression modulator, whereas Thymosin Beta-4 is a signaling modulator and a protein interaction inhibitor. MOTS-c has a more mitochondrial-encoded origin, while Thymosin Beta-4 is closer to natural endogenous background with MOTS-c in Preclinical development and Thymosin Beta-4 in Clinical phase 2. Thymosin Beta-4 incorporates acetylation features that are not part of MOTS-c, while their sequence patterns also diverge, with MOTS-c showing hydrophobic domain features and Thymosin Beta-4 showing protein-mimetic sequence features.